Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection. by Denise F Johnson, LaShaunda L Malone, Sarah Zalwango, Joy Mukisa Oketcho, Keith A Chervenak, Bonnie Thiel, Harriet Mayanja-Kizza, Catherine M Stein, W Henry Boom, Christina L Lancioni, Tuberculosis Research Unit

Get full text

Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count. by C Scott Mahan, Maria Walusimbi, Denise F Johnson, Christina Lancioni, Edwin Charlebois, Joyce Baseke, Keith A Chervenak, Roy D Mugerwa, Diane V Havlir, Harriet Mayanja-Kizza, Christopher C Whalen, W Henry Boom, Uganda-Case Western Research Collaboration

Get full text

Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infection. by Bonnie A Thiel, William Worodria, Sophie Nalukwago, Mary Nsereko, Ingvar Sanyu, Lalitha Rejani, Josephine Zawedde, David H Canaday, Catherine M Stein, Keith A Chervenak, LaShaunda L Malone, Ronald Kiyemba, Richard F Silver, John L Johnson, Harriet Mayanja-Kizza, W Henry Boom

Get full text